A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Purpose
This study will evaluate the efficacy and safety of Armour Thyroid treatment compared with synthetic T4 in subjects who have primary hypothyroidism and are currently stabilized (i.e., in-range thyroid-stimulating hormone [TSH]) on synthetic T4 treatment. This study will also therefore evaluate the efficacy and safety of dose conversion from synthetic T4 therapy to Armour Thyroid therapy.
Condition
- Hypothyroidism
Eligibility
- Eligible Ages
- Between 18 Years and 75 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Have a diagnosis of primary hypothyroidism made >= 12 months prior to Screening. - Be on continuous thyroid replacement therapy of synthetic T4 for primary hypothyroidism for at least 12 months immediately prior to the Screening Visit. - Be on a stable FDA-approved daily dose of synthetic T4 prior to the Screening visit, and must be taking synthetic T4 dose of at least 25 mcg at Screening visit. Must enter the study using the same stable dose to determine dose conversion. - Documentation of 1 in-range thyroid-stimulating hormone (TSH) (i.e., within 0.45 - 4.12 mIU/L, inclusive) at Screening and at least 1 additional in range TSH (i.e., within 0.45 - 4.12 mIU/L, inclusive) taken at a minimum of 6 weeks and a maximum of 12 months prior to Screening.
Exclusion Criteria
- Any clinical condition or previous surgery that might affect the absorption, distribution, biotransformation, or excretion of Armour Thyroid or synthetic T4. - History of alcohol or other substance abuse within the previous 6 months prior to the Screening. - Known or suspected allergy or intolerance to any ingredients of Armour Thyroid, including its excipients, synthetic T4, other thyroid replacement medications, or pork products.
Study Design
- Phase
- Phase 2/Phase 3
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Treatment
- Masking
- Triple (Participant, Care Provider, Investigator)
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Experimental Group 1 |
Participants will receive Armour Thyroid for up to 81 weeks. |
|
Experimental Group 2 |
Participants will alternate between Armour Thyroid and synthetic T4 for up to 81 weeks. |
|
Recruiting Locations
Birmingham, Alabama 35205
Site Coordinator
205-327-1090
Birmingham, Alabama 35233-1932
Bonita, California 91902-1230
Burbank, California 91505-4554
Concord, California 94520
Site Coordinator
925-687-8860
Encinitas, California 92024
Fullerton, California 92835
Greenbrae, California 94904
Huntington Park, California 90255-2951
La Jolla, California 92037
Mission Hills, California 91345
Newport Beach, California 92663
Orange, California 92866-2862
Pomona, California 91766
San Mateo, California 94404
Santa Clarita, California 91321
Santa Clarita, California 91355-4462
Torrance, California 90502
Walnut Creek, California 94598
West Hills, California 91304-3837
Bridgeport, Connecticut 06606
Clearwater, Florida 33756-2004
Site Coordinator
(727) 584-6368
Cooper City, Florida 33024
Fleming Island, Florida 32003
Fleming Island, Florida 32003
Site Coordinator
904-541-8225
Fort Lauderdale, Florida 33312
Site Coordinator
(954) 963-7191
Hollywood, Florida 33021
Jacksonville, Florida 32204
Jacksonville, Florida 32207-4966
Jacksonville, Florida 32216
Site Coordinator
(904) 740-4107
Jacksonville, Florida 32216
Jacksonville, Florida 32258
Margate, Florida 33063
Miami Springs, Florida 33166
Site Coordinator
305-885-8983
Miami, Florida 33186
Mount Dora, Florida 32757
Site Coordinator
352-374-0022
New Port Richey, Florida 34652
Site Coordinator
727-849-4131
Ocoee, Florida 34761-4547
Palm Harbor, Florida 34684
Site Coordinator
727-849-4131
Plantation, Florida 33317-2911
Saint Augustine, Florida 32080
Site Coordinator
904-541-8225
West Palm Beach, Florida 33401
Site Coordinator
561-802-3060
Atlanta, Georgia 30303
Atlanta, Georgia 30318
Canton, Georgia 30114
Columbus, Georgia 31904
Lawrenceville, Georgia 30046
Macon, Georgia 31210
Roswell, Georgia 30076
Site Coordinator
678-878-4750
Honolulu, Hawaii 96813
Idaho Falls, Idaho 83404-7596
Chicago, Illinois 60611-2927
Council Bluffs, Iowa 51501-3822
West Des Moines, Iowa 50266
Topeka, Kansas 66606
Louisville, Kentucky 40202
Louisville, Kentucky 40213-1014
Baton Rouge, Louisiana 70808
Metairie, Louisiana 70006-2930
Metairie, Louisiana 70006-2930
Boston, Massachusetts 02111-1552
Dracut, Massachusetts 01826
Dearborn, Michigan 48126
Farmington Hills, Michigan 48334-1566
Flint, Michigan 48532
Chesterfield, Missouri 63017
Columbia, Missouri 65212
Jefferson City, Missouri 65109
Saint Louis, Missouri 63104
Saint Louis, Missouri 63110
Springfield, Missouri 65804
Billings, Montana 59101-0733
Butte, Montana 59701-1652
Lincoln, Nebraska 68516
Site Coordinator
402-481-8128
Omaha, Nebraska 68114
Las Vegas, Nevada 89148
Reno, Nevada 89511
Nashua, New Hampshire 03060
Albany, New York 12203
Buffalo, New York 14203
New York, New York 10001
Smithtown, New York 11787
Greenville, North Carolina 27834
Morehead City, North Carolina 28557
Site Coordinator
252-499-8658
Morehead City, North Carolina 28557
Morehead City, North Carolina 28557
Site Coordinator
828-322-7338
Salisbury, North Carolina 28144-2735
Wilmington, North Carolina 28401
Canton, Ohio 44718
Cleveland, Ohio 44195
Columbus, Ohio 43203
Norman, Oklahoma 73072
Oklahoma City, Oklahoma 73112
Feasterville-Trevose, Pennsylvania 19053
Philadelphia, Pennsylvania 19107
Philadelphia, Pennsylvania 19114-1025
Sayre, Pennsylvania 18840
Myrtle Beach, South Carolina 29572
North Charleston, South Carolina 29406-9823
Summerville, South Carolina 29485
Site Coordinator
843-851-7098
Chattanooga, Tennessee 37404-3239
Knoxville, Tennessee 37938
Site Coordinator
(865) 263-6875
Memphis, Tennessee 38103
Memphis, Tennessee 38115
Nashville, Tennessee 37203
Austin, Texas 78731
Site Coordinator
512-334-3505
Austin, Texas 78749
Corpus Christi, Texas 78414
Dallas, Texas 75231
El Paso, Texas 79935
Fort Worth, Texas 76132
Houston, Texas 77040
Houston, Texas 77043
Houston, Texas 77079-2204
Houston, Texas 77095
Irving, Texas 75039
Mesquite, Texas 75149
Round Rock, Texas 78681
Site Coordinator
210-614-8612
San Antonio, Texas 78233
Site Coordinator
210-581-0045
San Antonio, Texas 78237
Site Coordinator
210-614-8612Ex210
Shavano Park, Texas 78231
Site Coordinator
210.291.3797
Weslaco, Texas 78596
Ogden, Utah 84405-6779
Site Coordinator
(801) 409-2040
South Burlington, Vermont 05403
Chesapeake, Virginia 23321
Richmond, Virginia 23249
Salem, Virginia 24153
Site Coordinator
540 982 2463 x 4973
Renton, Washington 98055
Site Coordinator
888-478-8343
Spokane, Washington 99202
Tacoma, Washington 98405
Bayamon, Puerto Rico 00960
Guaynabo, Puerto Rico 00969-2806
San Juan, Puerto Rico 00907-1510
San Juan, Puerto Rico 00917
Site Coordinator
787-936-2100
San Juan, Puerto Rico 00918-3756
More Details
- NCT ID
- NCT06345339
- Status
- Recruiting
- Sponsor
- AbbVie